- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2019
- Schlagwort
-
Melanoma
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2019
- Urheber
-
Granados Blanco, Karol Andrea
- Beteiligte Personen und Organisationen
-
Umansky, Viktor
- DOI
-
10.11588/heidok.00027601
- URN
-
urn:nbn:de:bsz:16-heidok-276019
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Granados Blanco, Karol Andrea
- Umansky, Viktor
- Universitätsbibliothek Heidelberg
Entstanden
- 2019
Ähnliche Objekte (12)
Glutathione-dependent reprogramming in melanoma
Androgen receptor is a determinant of melanoma targeted drug resistance
Single-cell trajectories of melanoma cell resistance to targeted treatment
Melanoma : Biologically Targeted Therapeutics
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Reversing endothelial cell aging by partial reprogramming
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Partial reprogramming of melanoma cells mimics the phenotype switch and reveals SNAI3 as a novel invasion-associated marker
Partial reprogramming of melanoma cells mimics the phenotype switch and reveals SNAI3 as a novel invasion-associated marker
Targeted removal of epigenetic barriers during transcriptional reprogramming
Glutathione-dependent reprogramming in melanoma
Androgen receptor is a determinant of melanoma targeted drug resistance
Single-cell trajectories of melanoma cell resistance to targeted treatment
Melanoma : Biologically Targeted Therapeutics
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Reversing endothelial cell aging by partial reprogramming
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Partial reprogramming of melanoma cells mimics the phenotype switch and reveals SNAI3 as a novel invasion-associated marker
Partial reprogramming of melanoma cells mimics the phenotype switch and reveals SNAI3 as a novel invasion-associated marker
Targeted removal of epigenetic barriers during transcriptional reprogramming
Glutathione-dependent reprogramming in melanoma
Androgen receptor is a determinant of melanoma targeted drug resistance
Single-cell trajectories of melanoma cell resistance to targeted treatment
Melanoma : Biologically Targeted Therapeutics
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Role of Id3 in melanoma dedifferentiation and resistance to targeted therapy
Reversing endothelial cell aging by partial reprogramming
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
The role of FOXD1 in melanoma dedifferentiation and resistance towards targeted therapy
Partial reprogramming of melanoma cells mimics the phenotype switch and reveals SNAI3 as a novel invasion-associated marker
Partial reprogramming of melanoma cells mimics the phenotype switch and reveals SNAI3 as a novel invasion-associated marker